|
|
News Breaks
|
May 3, 2011
|
| 18:18 EDT |  | MAXY |
| theflyonthewall.com: | Maxygen submitts proposal to the BARDA for development of MAXY-G34 | | Maxygen announced that it has submitted a proposal to the Biomedical Advanced Research and Development Authority, or BARDA, a multi-year, multi-million dollar contract for the development of its MAXY-G34 product candidate as a potential medical countermeasure for Acute Radiation Syndrome, or ARS. ARS results from exposure to high doses of ionizing radiation, such as from a nuclear explosion, improvised nuclear device detonation or radiation leak from a nuclear power facility. The hematopoietic sub-syndrome of ARS is characterized by the onset of severe neutropenia, which in combination with gastrointestinal and skin damage can lead to opportunistic infections and death. :theflyonthewall.com |
|
|
News For MAXY From The Last 14 Days Check below for free stories on MAXY the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 14, 2012
|
| 09:03 EDT | | MAXY |
|
|
|
|
|
Subscribe for More Information